← All trials
NCT05985655
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 6, 2023
- Primary completion
- Jan 31, 2028
- Completion date
- May 31, 2028
- First posted
- Aug 14, 2023
- Last posted
- Oct 19, 2023
- Enrollment
- 170
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Recursion Pharmaceuticals Inc.Lead sponsor
- Exscientia LimitedLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.